Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
37.5%
% of PPH's 27 holdings also in PJP
30.0%
% of PJP's 30 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH | Weight in PJP | Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 6.5% | 5.2% | 5.2% |
|
JOHNSON & JOHNSON | 6.6% | 5.1% | 5.1% |
|
MERCK & CO. INC. | 4.8% | 5.0% | 4.8% |
|
ELI LILLY & CO | 11.9% | 4.7% | 4.7% |
|
PFIZER INC | 4.4% | 4.9% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to PJP
|
ELI LILLY & CO | 7.2% |
 |
NOVARTIS AG-ADR | 5.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
|
CENCORA INC | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.9% |
|
MCKESSON CORP | 4.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.7% |
|
ZOETIS INC | 4.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% |
PPH Underweight Relative to PJP
|
GILEAD SCIENCES INC | -5.2% |
|
AMGEN INC | -5.0% |
|
ABBOTT LABORATORIES | -5.0% |
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
BIOSANTE PHARMACEUTICALS INC | -3.5% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
INNOVIVA, INC. | -2.8% |
|
PACIRA PHARMACEUTICALS INC | -2.8% |
|
SUPERNUS PHARMACEUTICALS INC | -2.8% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.7% |